Literature DB >> 25238005

Inhaled drug delivery in the hands of the patient.

Federico Lavorini1.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are both diseases with an increasing prevalence worldwide. Inhaled therapy for these conditions has a number of advantages over systemic therapy, but requires the patients to use, and to master the use of, an inhaler device. However, many patients cannot use inhalers correctly, and over 50% of patients struggle to use a metered-dose inhaler properly. Poor inhaler technique is associated with a reduced asthma control, worst COPD outcomes, and wastage of economic resources. Of perhaps more concern is the fact that many health professionals also do not know how to use inhalers correctly and are therefore not in a position to coach patients effectively. Training patients and caregivers in the correct inhaler preparation and use is an essential component in the process toward achieving reliable and repeatable medication delivery. Instructions should be inhaler-specific, and they include instruction on how to load or prime the device. Providing only the leaflet that comes with the medicines does not lead to adequate inhalation technique, not even immediately after the patient has read the instructions and practiced with the inhaler. One-on-one sessions with health-care professionals probably represent the most effective educational method. However, it appears that, by itself, even repeated instruction could be insufficient to achieve improved adherence in the long term, as there is a tendency for patients or caregivers to forget what they have learned as time elapses since the training event. Thus, despite the development of several new and improved types of inhaler device, the evidence currently available points to little or no progress having been made with patients' ability to use their inhalers. As the range of drugs delivered by inhalation increases, inhaler technique checks and training need to be an integral part of the routine management of any patient with either asthma or COPD.

Entities:  

Keywords:  COPD; asthma; dry powder inhalers; inhaled therapy; metered-dose inhalers

Mesh:

Substances:

Year:  2014        PMID: 25238005     DOI: 10.1089/jamp.2014.1132

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  14 in total

Review 1.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 2.  Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.

Authors:  Timothy E Albertson; Richart Harper; Susan Murin; Christian Sandrock
Journal:  Patient Prefer Adherence       Date:  2015-02-02       Impact factor: 2.711

Review 3.  Asthma control: the right inhaler for the right patient.

Authors:  Nicola Scichilone
Journal:  Adv Ther       Date:  2015-04-07       Impact factor: 3.845

4.  Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease.

Authors:  Alpesh N Amin; Vaidyanathan Ganapathy; Adam Roughley; Mark Small
Journal:  Patient Prefer Adherence       Date:  2017-07-12       Impact factor: 2.711

5.  Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.

Authors:  David Price; Dorothy L Keininger; Boomi Viswanad; Matthias Gasser; Susann Walda; Florian S Gutzwiller
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-26

Review 6.  Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.

Authors:  Antonio Molino; Giovanna Calabrese; Mauro Maniscalco
Journal:  Patient Prefer Adherence       Date:  2018-06-08       Impact factor: 2.711

7.  Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.

Authors:  David B Price; Sen Yang; Simon Wan Yau Ming; Antony Hardjojo; Claudia Cabrera; Andriana I Papaioannou; Stelios Loukides; Vicky Kritikos; Sinthia Z Bosnic-Anticevich; Victoria Carter; Paul M Dorinsky
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-13

8.  COPD: misuse of inhaler devices in clinical practice.

Authors:  A Duarte-de-Araújo; P Teixeira; V Hespanhol; J Correia-de-Sousa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-30

9.  Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians.

Authors:  David Price; Brooke Harrow; Mark Small; James Pike; Victoria Higgins
Journal:  World Allergy Organ J       Date:  2015-09-10       Impact factor: 4.084

Review 10.  Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®).

Authors:  Pieter Nicolaas Richard Dekhuijzen; Federico Lavorini; Omar S Usmani
Journal:  Patient Prefer Adherence       Date:  2016-08-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.